Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Impact of Previous Invasive Fungal Infections on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cells

Gaetano Maffongelli, Sr., PhD, Gaetano Maffongelli, Sr., PhD, Gaetano Maffongelli, Sr., PhD, Laura Cudillo, MD, Fabio Di Piazza, MSc, Vincenzo Malagnino, Giovanna de Santis, Benedetta Mariotti, Eleonora Ceresoli, Raffaella Cerretti, MD, Alessandra Picardi, MD, Massimo Andreoni, William Arcese, MD, Loredana Sarmati

Blood (2016) 128 (22): 5748.

https://doi.org/10.1182/blood.V128.22.5748.5748

Published: 2016

Journal Articles

Evolving Criteria of Donor Selection for Allogeneic Transplant in Acute Myeloid Leukemia

Blood (2015) 126 (23): 2004.

https://doi.org/10.1182/blood.V126.23.2004.2004

Published: 2015

Journal Articles

Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia

Francesco Buccisano, MD, Luca Maurillo, MD, Alfonso Piciocchi, Maria Ilaria Del Principe, MD, Gottardo De Angelis, MD, Ambra Di Veroli, MD, Raffaella Cerretti, MD, Mariagiovanna Cefalo, MD, Concetta Ditto, MD, Alessandra Picardi, MD, Laura Cudillo, MD, Benedetta Mariotti, MD, Francesco Lo Coco, MD, William Arcese, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2015) 126 (23): 3230.

https://doi.org/10.1182/blood.V126.23.3230.3230

Published: 2015

Journal Articles

Haploidentical, G-CSF Primed, Unmanipulated Bone Marrow Transplantation with Anti-CD25 Monoclonal Antibody As Part of the Gvhd Prophylaxis for Patients with High-Risk Acute Myeloid Leukemia

Blood (2015) 126 (23): 4368.

https://doi.org/10.1182/blood.V126.23.4368.4368

Published: 2015

Journal Articles

Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network

Blood (2014) 124 (21): 1223.

https://doi.org/10.1182/blood.V124.21.1223.1223

Published: 2014

Journal Articles

Allogeneic but Not Autologous Stem Cell Transplant Attenuates the Negative Prognostic Impact Dictated By Pretransplant MRD Positivity

Francesco Buccisano, MD, Luca Maurillo, MD, Maria Ilaria Del Principe, Gottardo De Angelis, MD, Raffaella Cerretti, MD, Concetta Ditto, MD, Ambra Di Veroli, MD, Alessandra Picardi, MD, Laura Cudillo, MD, Mariagiovanna Cefalo, MD, Chiara Sarlo, MD, Giorgia Fedele, MD, Marco Refrigeri, MD, Francesco Lo Coco, MD, William Arcese, MD, Sergio Amadori, Adriano Venditti

Blood (2014) 124 (21): 2363.

https://doi.org/10.1182/blood.V124.21.2363.2363

Published: 2014

Journal Articles

Haploidentical, Unmanipulated, G-CSF-Primed Bone Marrow Transplantation For Patients With High-Risk Acute Myeloid Leukemia

William Arcese, MD, Raffaella Cerretti, MD, Stella Santarone, MD, Alessandra Picardi, MD, Manuela Testi, Laura Cudillo, MD, Francesco Buccisano, MD, Teresa Dentamaro, MD, Fabio Di Piazza, Gottardo De Angelis, Paolo Di Bartolomeo, MD

Blood (2013) 122 (21): 3356.

https://doi.org/10.1182/blood.V122.21.3356.3356

Published: 2013

Journal Articles

Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies

Paolo Di Bartolomeo, Stella Santarone, Gottardo De Angelis, Alessandra Picardi, Laura Cudillo, Raffaella Cerretti, Gaspare Adorno, Stefano Angelini, Marco Andreani, Lidia De Felice, Maria Cristina Rapanotti, Loredana Sarmati, Pasqua Bavaro, Gabriele Papalinetti, Marta Di Nicola, Franco Papola, Mauro Montanari, Arnon Nagler, William Arcese

Blood (2013) 121 (5): 849–857.

https://doi.org/10.1182/blood-2012-08-453399

Published: 2013

Journal Articles

Unmanipulated, G-CSF-Primed Bone Marrow Transplantation From Haploidentical Donor for Patients with High-Risk Acute Myeloid Leukemia.

William Arcese, MD, Raffaella Cerretti, MD, Stella Santarone, MD, Gottardo De Angelis, MD, Pasqua Bavaro, MD, Manuela Testi, MD, Laura Cudillo, MD, Alessandra Picardi, MD, Elsa Pennese, MD, Gabriele Papalinetti, MD, Teresa Dentamaro, MD, Eleonora Ceresoli, MD, Benedetta Mariotti, MD, Fabio Di Piazza, Paolo Di Bartolomeo, MD

Blood (2012) 120 (21): 3122.

https://doi.org/10.1182/blood.V120.21.3122.3122

Published: 2012

Journal Articles

Unmanipulated Bone Marrow Transplantation From Haploidentical Related Donor for Patients with High-Risk Hematological Malignancies

Paolo Di Bartolomeo, MD, Stella Santarone, MD, Gottardo De Angelis, Alessandra Picardi, Pasqua Bavaro, Erminia Di Bartolomeo, Paola Olioso, Marta Di Nicola, Lidia De Felice, Laura Cudillo, Raffaella Cerretti, William Arcese

Blood (2010) 116 (21): 2350.

https://doi.org/10.1182/blood.V116.21.2350.2350

Published: 2010

Journal Articles

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Blood (2009) 114 (22): 1195.

https://doi.org/10.1182/blood.V114.22.1195.1195

Published: 2009

Journal Articles

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti–thymocyte globulin

Maria Teresa Van Lint, Giuseppe Milone, Salvatore Leotta, Cornelio Uderzo, Rosanna Scimè, Sandro Dallorso, Anna Locasciulli, Stefano Guidi, Nicola Mordini, Simona Sica, Laura Cudillo, Franca Fagioli, Carmine Selleri, Barbara Bruno, William Arcese, Andrea Bacigalupo, for the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Blood (2006) 107 (10): 4177–4181.

https://doi.org/10.1182/blood-2005-12-4851

Published: 2006

Journal Articles

Efficacy of Caspofungin as Secondary Prophylaxis in Patients Undergoing Stem Cell Transplantation with Prior Pulmonary and/or Systemic Fungal Infection.

Paolo de Fabritiis, MD, Laura Cudillo, MD, Paolo Di Bartolomeo, MD, Anna Locasciulli, MD, Giuseppe Milone, MD, Stefania Fallani, PhD, Alessandro Busca, MD, Rosanna Scimè, MD, Simona Sica, MD, Alessandra Spagnoli, Statistic, Stella Santarone, MD, Ignazio Majolino, MD, Massimo Poidomani, MD, Andrea Novelli, PhD

Blood (2005) 106 (11): 3225.

https://doi.org/10.1182/blood.V106.11.3225.3225

Published: 2005

Journal Articles

Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia: Presented in part at the 41st Annual Meeting of the American Society of Hematology, December 3-7, 1999, New Orleans, LA.

Adriano Venditti, Francesco Buccisano, Giovanni Del Poeta, Luca Maurillo, Anna Tamburini, Christina Cox, Alessandra Battaglia, Gianfranco Catalano, Beatrice Del Moro, Laura Cudillo, Massimiliano Postorino, Mario Masi, Sergio Amadori

Blood (2000) 96 (12): 3948–3952.

https://doi.org/10.1182/blood.V96.12.3948

Published: 2000

NARROW

Impact of Previous Invasive Fungal Infections on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cells

Evolving Criteria of Donor Selection for Allogeneic Transplant in Acute Myeloid Leukemia

Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia

Haploidentical, G-CSF Primed, Unmanipulated Bone Marrow Transplantation with Anti-CD25 Monoclonal Antibody As Part of the Gvhd Prophylaxis for Patients with High-Risk Acute Myeloid Leukemia

Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network

Allogeneic but Not Autologous Stem Cell Transplant Attenuates the Negative Prognostic Impact Dictated By Pretransplant MRD Positivity

Haploidentical, Unmanipulated, G-CSF-Primed Bone Marrow Transplantation For Patients With High-Risk Acute Myeloid Leukemia

Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies

Unmanipulated, G-CSF-Primed Bone Marrow Transplantation From Haploidentical Donor for Patients with High-Risk Acute Myeloid Leukemia.

Unmanipulated Bone Marrow Transplantation From Haploidentical Related Donor for Patients with High-Risk Hematological Malignancies

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti–thymocyte globulin

Efficacy of Caspofungin as Secondary Prophylaxis in Patients Undergoing Stem Cell Transplantation with Prior Pulmonary and/or Systemic Fungal Infection.

Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia: Presented in part at the 41st Annual Meeting of the American Society of Hematology, December 3-7, 1999, New Orleans, LA.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only